NORTH ANDOVER, Mass., Sept. 5 /PRNewswire-FirstCall/ -- Andover Medical, Inc. , a single source provider of orthopedic, podiatric and urological durable medical equipment ("DME") and incontinence treatment solutions, announced today that unauthorized emails using Andover Medical's name and ticker symbol were distributed to the investment community.
The Company has no knowledge of the source of the emails, but confirms that the information contained in them is untrue.
Please direct any questions or additional information regarding this issue to Erin Hegarty, Equity Performance Group, at 617-723-2225 or erin@equityperfgp.com.
About Andover Medical Inc.:
Andover Medical, Inc. (AMI) is building a single source provider of orthopedic, podiatric and urological durable medical equipment ("DME") and incontinence treatment solutions. The Company intends to establish a nationwide subsidiary network and plans to offer practitioners the largest selection of competitively priced brand-name durable medical equipment, and urodynamic diagnostic and treatment products. For more information, please call (978) 557-1001 or visit http://www.andovermedical.com.
Forward-Looking Statements:
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These forward looking statements include: Andover's intent to establish a nationwide subsidiary network and plans to offer physicians the largest selection of competitively priced brand-name products; and Andover is more favorably positioned to execute as we build-out and realize the synergies from the creation of this national network.
Andover Medical, Inc.CONTACT: Investor Relations, Erin Hegarty of Equity Performance Group,+1-617-723-2225, erin@equityperfgp.com
Web site: http://www.andovermedical.com/
